Several mechanisms have been proposed to account for this including aberrant PKA activation [37], deficits of upstream mobilizing agonists and signaling molecules such as SDF-1α, VEGF and nitric oxide [25, 33, 38], and impaired β-adrenergic responsiveness and neuropathy [39, 40]. This evidence concerns the gene CXCL12 and neuropathy.